Literature DB >> 2003867

High-resolution PET studies in Alzheimer's disease.

A Kumar1, M B Schapiro, C Grady, J V Haxby, E Wagner, J A Salerno, R P Friedland, S I Rapoport.   

Abstract

Forty-seven patients with probable dementia of the Alzheimer type (DAT) and 30 healthy age-matched controls were scanned using [18F]-2-fluoro-2-deoxy-D-glucose on a Scanditronix PC 1024-7B tomograph (inplane resolution = 6 mm, axial resolution = 10 mm). Patients and controls were scanned in the resting state with their eyes patched and ears occluded. The regional cerebral metabolic rates for glucose (rCMRglc) in most major neocortical and subcortical gray matter regions, and certain metabolic ratios (rCMRglc/ calcarine rCMRglc), quantitatively discriminated even the mildly demented patients from healthy controls. The association neocortices showed metabolic abnormalities that were more severe than those in the sensorimotor and calcarine regions. All demented groups showed significant neuropsychological disturbances when compared to healthy controls. These data demonstrated widespread metabolic disturbances, particularly in the association areas, relatively early in Alzheimer's disease, and more profound involvement with disease progression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003867

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  21 in total

Review 1.  A meta-analysis of structural and functional brain imaging in dementia of the Alzheimer's type: a neuroimaging profile.

Authors:  Konstantine K Zakzanis; Simon J Graham; Zachariah Campbell
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

2.  Sustained attention in mild Alzheimer's disease.

Authors:  Anna Maria Berardi; Raja Parasuraman; James V Haxby
Journal:  Dev Neuropsychol       Date:  2005       Impact factor: 2.253

Review 3.  [Default mode network of the brain. Neurobiology and clinical significance].

Authors:  A Otti; H Gündel; A Wohlschläger; C Zimmer; C Sorg; M Noll-Hussong
Journal:  Nervenarzt       Date:  2012-01       Impact factor: 1.214

4.  Relationships between cognitive impairment on ADAS-cog and regional cerebral blood flow using SPECT in late-onset Alzheimer's disease.

Authors:  Michio Takahashi; Yasunori Oda; Toshiyuki Okubo; Yukihiko Shirayama
Journal:  J Neural Transm (Vienna)       Date:  2017-05-16       Impact factor: 3.575

5.  Biomarkers and evolution in Alzheimer disease.

Authors:  Stanley I Rapoport; Peter T Nelson
Journal:  Prog Neurobiol       Date:  2011-07-23       Impact factor: 11.685

6.  Disturbed neurotransmitter transporter expression in Alzheimer's disease brain.

Authors:  Kevin H Chen; Edmund A Reese; Hyung-Wook Kim; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 7.  Probing the biology of Alzheimer's disease in mice.

Authors:  Karen H Ashe; Kathleen R Zahs
Journal:  Neuron       Date:  2010-06-10       Impact factor: 17.173

Review 8.  [Visual search in healthy persons and Alzheimer's patients: relating cognitive function to clinical practice].

Authors:  A Rösler; N Müller
Journal:  Nervenarzt       Date:  2003-10       Impact factor: 1.214

9.  Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET.

Authors:  Giuseppe Esposito; Giampiero Giovacchini; Jeih-San Liow; Abesh K Bhattacharjee; Dede Greenstein; Mark Schapiro; Mark Hallett; Peter Herscovitch; William C Eckelman; Richard E Carson; Stanley I Rapoport
Journal:  J Nucl Med       Date:  2008-08-14       Impact factor: 10.057

10.  Reductions in parietal and temporal cerebral metabolic rates for glucose are not specific for Alzheimer's disease.

Authors:  M B Schapiro; P Pietrini; C L Grady; M J Ball; C DeCarli; A Kumar; J A Kaye; J V Haxby
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-08       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.